|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-11-2
|
|
pubmed:abstractText |
All-trans-retinoic acid (ATRA) is a new and effective treatment of acute promyelocytic leukemia. It has many side-effects, including the retinoic acid syndrome and Sweet's syndrome. There have been only nine cases of hypercalcemia associated with ATRA described in the literature. We discuss a case of hypercalcemia, which we believe was due to inhibition of cytochrome P450 function by voriconizole when used concomitantly with ATRA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1042-8194
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1829-31
|
|
pubmed:meshHeading |
pubmed-meshheading:16263588-Adult,
pubmed-meshheading:16263588-Antifungal Agents,
pubmed-meshheading:16263588-Antineoplastic Agents,
pubmed-meshheading:16263588-Female,
pubmed-meshheading:16263588-Humans,
pubmed-meshheading:16263588-Hypercalcemia,
pubmed-meshheading:16263588-Leukemia, Promyelocytic, Acute,
pubmed-meshheading:16263588-Pyrimidines,
pubmed-meshheading:16263588-Treatment Outcome,
pubmed-meshheading:16263588-Tretinoin,
pubmed-meshheading:16263588-Triazoles
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole.
|
|
pubmed:affiliation |
Department of Medicine, University of British Columbia, Vancouver, BC, Canada. matthebe@interchange.ubc.ca
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
